$NTLA 4 SEC Filings

Filed On	Filing
06 Oct 2026	Form 4: Dube Michael P, VP, Chief Accounting Officer Sold 1,864 shares ($23.2K)
24 Aug 2026	Form 4: Leonard John M, Director Sold 19,890 shares ($251K) · Sold 2,785 shares ($36.2K)
24 Jul 2026	Form 4: Dulac Edward J Iii, EVP, Chief Financial Officer Sold 8,111 shares ($91.2K)
06 Jul 2026	Form 4: Dube Michael P, VP, Chief Accounting Officer Sold 2,641 shares ($44.3K)
06 Jul 2026	Form 4: Dulac Edward J Iii, EVP, Chief Financial Officer Sold 4,677 shares ($84.2K)
10 Jun 2026	Form 4: Cohen Fred E, Director Received 9,200 shares as a grant or award · Granted 13,300 Stock Option (right to buy)
10 Jun 2026	Form 4: Goodman Jesse, Director Received 9,200 shares as a grant or award · Granted 13,300 Stock Option (right to buy)
10 Jun 2026	Form 4: Goff Brian, Director Received 9,200 shares as a grant or award · Granted 13,300 Stock Option (right to buy)
10 Jun 2026	Form 4: Verwiel Frank, Director Received 9,200 shares as a grant or award · Granted 13,300 Stock Option (right to buy)
10 Jun 2026	Form 4: Keresty Georgia, Director Received 9,200 shares as a grant or award · Granted 13,300 Stock Option (right to buy)
10 Jun 2026	Form 4: Bhanji Muna, Director Received 9,200 shares as a grant or award · Granted 13,300 Stock Option (right to buy)
10 Jun 2026	Form 4: Chase William J, Director Received 9,200 shares as a grant or award · Granted 13,300 Stock Option (right to buy)
03 Mar 2026	Form 4: Basta James, EVP, General Counsel Received 46,080 shares as a grant or award · Granted 65,829 Stock Option (right to buy) · Sold 1,211 shares ($16.7K)
03 Mar 2026	Form 4: Leonard John M, Director Received 156,400 shares as a grant or award · Granted 225,400 Stock Option (right to buy)
03 Mar 2026	Form 4: Lebwohl David, EVP, Chief Medical Officer Received 9,943 shares as a grant or award · Granted 14,204 Stock Option (right to buy)
03 Mar 2026	Form 4: Dulac Edward J Iii, EVP, Chief Financial Officer Received 61,280 shares as a grant or award · Granted 87,543 Stock Option (right to buy)
03 Mar 2026	Form 4: Schultes Birgit C, EVP, Chief Scientific Officer Received 39,200 shares as a grant or award · Granted 56,000 Stock Option (right to buy)
03 Mar 2026	Form 4: Clark Eliana, EVP, Chief Technical Officer Received 7,353 shares as a grant or award · Granted 10,505 Stock Option (right to buy) · Sold 607 shares ($8.36K)
03 Mar 2026	Form 4: Dube Michael P, VP, Chief Accounting Officer Received 17,250 shares as a grant or award
07 Jan 2026	Form 4: Leonard John M, Director Sold 34,146 shares ($314K)

Comments